- Home
- INDP vs MEGL Comparison
INDP vs MEGL Comparison
Compare INDP & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- MEGL
- Stock Information
- Founded
- INDP 2000
- MEGL 2016
- Country
- INDP United States
- MEGL Hong Kong
- Employees
- INDP N/A
- MEGL N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- MEGL Finance: Consumer Services
- Sector
- INDP Health Care
- MEGL Finance
- Exchange
- INDP Nasdaq
- MEGL Nasdaq
- Market Cap
- INDP 6.0M
- MEGL 6.8M
- IPO Year
- INDP N/A
- MEGL 2022
- Fundamental
- Price
- INDP $2.60
- MEGL $1.44
- Analyst Decision
- INDP Strong Buy
- MEGL
- Analyst Count
- INDP 2
- MEGL 0
- Target Price
- INDP $238.00
- MEGL N/A
- AVG Volume (30 Days)
- INDP 14.7K
- MEGL 27.8K
- Earning Date
- INDP 08-13-2025
- MEGL 10-29-2025
- Dividend Yield
- INDP N/A
- MEGL N/A
- EPS Growth
- INDP N/A
- MEGL N/A
- EPS
- INDP N/A
- MEGL N/A
- Revenue
- INDP N/A
- MEGL $1,645,862.00
- Revenue This Year
- INDP N/A
- MEGL N/A
- Revenue Next Year
- INDP N/A
- MEGL N/A
- P/E Ratio
- INDP N/A
- MEGL N/A
- Revenue Growth
- INDP N/A
- MEGL N/A
- 52 Week Low
- INDP $3.21
- MEGL $1.02
- 52 Week High
- INDP $58.24
- MEGL $5.52
- Technical
- Relative Strength Index (RSI)
- INDP 18.83
- MEGL 54.43
- Support Level
- INDP $6.26
- MEGL $1.30
- Resistance Level
- INDP $6.65
- MEGL $1.50
- Average True Range (ATR)
- INDP 0.76
- MEGL 0.07
- MACD
- INDP -0.33
- MEGL 0.01
- Stochastic Oscillator
- INDP 2.84
- MEGL 80.85
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.